Article Commentary: Clinical Medicine: Endocrinology and Diabetes: Insulin Resistance–-a Link between Inflammation and Hepatocarcinogenesis?

by Jörn M. Schattenberg
Published 2009-01-01

Assessing the disease burden of non-alcoholic fatty liver disease in the real world – big data and big numbers

by Jörn M. Schattenberg, Mattias Ekstedt
Published 2019-07-01

Nutritional Intake and the Risk for Non-Alcoholic Fatty Liver Disease (NAFLD)

by Jörn M. Schattenberg, Ina Bergheim
Published 2019-03-01

Beyond the Paradigm of Weight Loss in Non-Alcoholic Fatty Liver Disease: From Pathophysiology to Novel Dietary Approaches

by Angelo Armandi, Jörn M. Schattenberg
Published 2021-06-01

Regulation of the effects of CYP2E1-induced oxidative stress by JNK signaling

by Jörn M. Schattenberg, Mark J. Czaja
Published 2014-01-01

Noninvasive Testing Using Magnetic Resonance Imaging Techniques as Outcomes in Nonalcoholic Steatohepatitis Clinical Trials: How Full Is the Glass?

by Nabil Noureddin, Jörn M. Schattenberg, Naim Alkhouri, Mazen Noureddin
Published 2020-02-01

Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)

by Anika Nier, Yvonne Huber, Christian Labenz, Maurice Michel, Ina Bergheim, Jörn M. Schattenberg
Published 2020-03-01

Nonalcoholic Fatty Liver Disease Increases the Risk of Anxiety and Depression

by Christian Labenz, Yvonne Huber, Maurice Michel, Michael Nagel, Peter R. Galle, Karel Kostev, Jörn M. Schattenberg
Published 2020-09-01

Assessing physician preferences on future therapeutic options and diagnostic practices in non-alcoholic steatohepatitis

by Nigel Cook, Andreas Geier, Andreas Schmid, Gideon Hirschfield, Achim Kautz, Jörn M. Schattenberg, Maria-Magdalena Balp
Published 2020-04-01

The Patient Perspectives on Future Therapeutic Options in NASH and Patient Needs

by Nigel Cook, Andreas Geier, Andreas Schmid, Gideon Hirschfield, Achim Kautz, Jörn M. Schattenberg, Maria-Magdalena Balp
Published 2019-04-01

Impact of acute-on-chronic liver failure and decompensated liver cirrhosis on psychosocial burden and quality of life of patients and their close relatives

by Michael Nagel, Christian Labenz, Marcus A. Wörns, J. U. Marquardt, Peter R. Galle, Jörn M. Schattenberg, Marc Nguyen-Tat
Published 2020-01-01

Cardiovascular Risk Categories in Patients With Nonalcoholic Fatty Liver Disease and the Role of Low‐Density Lipoprotein Cholesterol

by Christian Labenz, Jürgen H. Prochaska, Yvonne Huber, Michael Nagel, Beate K. Straub, Philipp Wild, Peter R. Galle, Jörn M. Schattenberg
Published 2019-11-01

Combined effects of the PNPLA3 rs738409, TM6SF2 rs58542926, and MBOAT7 rs641738 variants on NAFLD severity: a multicenter biopsy-based study1

by Marcin Krawczyk, Monika Rau, Jörn M. Schattenberg, Heike Bantel, Anita Pathil, Münevver Demir, Johannes Kluwe, Tobias Boettler, Frank Lammert, Andreas Geier
Published 2017-01-01

The Impact of Liver Cell Injury on Health-Related Quality of Life in Patients with Chronic Liver Disease.

by Yvonne Alt, Anna Grimm, Liesa Schlegel, Annette Grambihler, Jens M Kittner, Jörg Wiltink, Peter R Galle, Marcus A Wörns, Jörn M Schattenberg
Published 2016-01-01

Risk factors for poorer health literacy in patients with liver cirrhosis.

by Leonard Kaps, Katharina Hildebrand, Michael Nagel, Maurice Michel, Wolfgang Maximilian Kremer, Max Hilscher, Peter R Galle, Jörn M Schattenberg, Marcus-Alexander Wörns, Christian Labenz
Published 2021-01-01

Determining a healthy reference range and factors potentially influencing PRO-C3 – A biomarker of liver fibrosis

by Elisabeth Erhardtsen, Daniel G.K. Rasmussen, Peder Frederiksen, Diana Julie Leeming, Diane Shevell, Lise Lotte Gluud, Morten Asser Karsdal, Guruprasad P. Aithal, Jörn M. Schattenberg
Published 2021-08-01

Toll-like receptor 1 as a possible target in non-alcoholic fatty liver disease

by Anja Baumann, Anika Nier, Angélica Hernández-Arriaga, Annette Brandt, Maria J. Lorenzo Pisarello, Cheng J. Jin, Esther Pilar, Amélia Camarinha-Silva, Jörn M. Schattenberg, Ina Bergheim
Published 2021-09-01

The Fatty Liver Assessment in Germany (FLAG) cohort study identifies large heterogeneity in NAFLD care

by Wolf Peter Hofmann, Peter Buggisch, Lisa Schubert, Nektarios Dikopoulos, Jeannette Schwenzer, Marion Muche, Gisela Felten, Renate Heyne, Patrick Ingiliz, Anna Schmidt, Kerstin Stein, Heiner Wedemeyer, Thomas Berg, Johannes Wiegand, Frank Lammert, Stefan Zeuzem, Jörn M. Schattenberg
Published 2020-12-01

Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease

by Marie Boyle, Dina Tiniakos, Jorn M. Schattenberg, Vlad Ratziu, Elisabetta Bugianessi, Salvatore Petta, Claudia P. Oliveira, Olivier Govaere, Ramy Younes, Stuart McPherson, Pierre Bedossa, Mette J Nielsen, Morten Karsdal, Diana Leeming, Stuart Kendrick, Quentin M. Anstee
Published 2019-09-01

The gut microbiota instructs the hepatic endothelial cell transcriptome

by Henning Formes, Joana P. Bernardes, Amrit Mann, Franziska Bayer, Giulia Pontarollo, Klytaimnistra Kiouptsi, Katrin Schäfer, Sebastian Attig, Teodora Nikolova, Thomas G. Hofmann, Jörn M. Schattenberg, Hristo Todorov, Susanne Gerber, Philip Rosenstiel, Tobias Bopp, Felix Sommer, Christoph Reinhardt
Published 2021-10-01